Skip to main content
Journal of Bacteriology logoLink to Journal of Bacteriology
. 1999 May;181(9):2789–2796. doi: 10.1128/jb.181.9.2789-2796.1999

PhhB, a Pseudomonas aeruginosa Homolog of Mammalian Pterin 4a-Carbinolamine Dehydratase/DCoH, Does Not Regulate Expression of Phenylalanine Hydroxylase at the Transcriptional Level

Jian Song 1,, Tianhui Xia 1, Roy A Jensen 1,*
PMCID: PMC93720  PMID: 10217769

Abstract

Pterin 4a-carbinolamine dehydratase is bifunctional in mammals. In addition to playing a catalytic role in pterin recycling in the cytoplasm, it plays a regulatory role in the nucleus, where it acts as a dimerization-cofactor component (called DCoH) for the transcriptional activator HNF-1α. A thus far unique operon in Pseudomonas aeruginosa contains a gene encoding a homolog (PhhB) of the regulatory dehydratase, together with genes encoding phenylalanine hydroxylase (PhhA) and aromatic aminotransferase (PhhC). Using complementation of tyrosine auxotrophy in Escherichia coli as a functional test, we have found that the in vivo function of PhhA requires PhhB. Strikingly, mammalian DCoH was an effective substitute for PhhB, and either one was effective in trans. Surprisingly, the required presence of PhhB for complementation did not reflect a critical positive regulatory effect of phhB on phhA expression. Rather, in the absence of PhhB, PhhA was found to be extremely toxic in E. coli, probably due to the nonenzymatic formation of 7-biopterin or a similar derivative. However, bacterial PhhB does appear to exert modest regulatory effects in addition to having a catalytic function. PhhB enhances the level of PhhA two- to threefold, as was demonstrated by gene inactivation of phhB in P. aeruginosa and by comparison of the levels of expression of PhhA in the presence and absence of PhhB in Escherichia coli. Experiments using constructs having transcriptional and translational fusions with a lacZ reporter indicated that PhhB activates PhhA at the posttranscriptional level. Regulation of PhhA and PhhB is semicoordinate; both PhhA and PhhB are induced coordinately in the presence of either l-tyrosine or l-phenylalanine, but PhhB exhibits a significant basal level of activity that is lacking for PhhA. Immunoprecipitation and affinity chromatography showed that PhhA and PhhB form a protein-protein complex.


Pterin-4a-carbinolamine dehydratase catalyzes the dehydration step in the cyclic regeneration of tetrahydrobiopterin (BH4), an essential cofactor required for the phenylalanine hydroxylase reaction (Fig. 1). During catalysis, BH4 is stoichiometrically oxidized to a 4a-hydroxytetrahydrobiopterin, which is then converted by carbinolamine dehydratase to quinonoid dihydrobiopterin. The latter compound is cycled back to BH4 by an NADH-dependent dihydropteridine reductase (12), as shown in Fig. 1B. The importance of carbinolamine dehydratase in the regeneration of BH4 has become apparent because mutations in the human gene which encode it result in hyperphenylalaninemia (29) and in the depigmentation disorder vitiligo (25). Affected human subjects were found to excrete large amounts of a chemically rearranged form of 6-biopterin, 7-biopterin (25). The latter is a potent inhibitor of phenylalanine hydroxylase, thereby interfering with phenylalanine catabolism and with biosynthesis of melanoid pigments. A nonenzymatic rearrangement of 6-biopterin to 7-biopterin occurs in the absence of carbinolamine dehydratase (4, 29). Thus, it appears that carbinolamine dehydratase stimulates the phenylalanine hydroxylation reaction, not only by regenerating the essential pterin cofactor but also by preventing the formation of the inhibitory 7-biopterin.

FIG. 1.

FIG. 1

(A) Physical map of the phh operon in P. aeruginosa. The endonuclease restriction sites are shown at the top. The arrows indicate the positions of the genes and the directions of transcription. Putative transcriptional terminators (circled t’s) are indicated. The proteins encoded by the genes are as follows: phhR, the ς54 transcriptional activator of the phh operon (28); phhA, phenylalanine hydroxylase; phhB, 4a-carbinolamine dehydratase; and phhC, aromatic aminotransferase (8). (B) Regeneration of the pterin cofactor for phenylalanine hydroxylase. The enzymes involved are as follows: PhhA, phenylalanine hydroxylase; PhhB, 4a-carbinolamine dehydratase; and DHPR, dihydropteridine reductase.

Recently, it became apparent as the result of entirely independent sequencing results that cytoplasmic carbinolamine dehydratase is synonymous with a nuclear regulatory protein, DCoH (3). DCoH stabilizes the dimeric state of HNF-1α, a homeodomain-containing protein which transcriptionally activates tissue-specific expression of a large number of genes in liver, intestine, and kidney (16). In addition, DCoH was found to be a maternal factor in rat eggs, where HNF1 transcriptional factors are absent (20). This evidence for an HNF1-independent function of DCoH was further indicated by the presence of DCoH in the eyes and the brains of rat embryos, which maintain cell types lacking HNF1 proteins (20).

In an earlier report, we identified homologs of mammalian phenylalanine hydroxylase and 4a-carbinolamine dehydratase/DCoH as two gene members of a three-component operon in Pseudomonas aeruginosa (34). Phenylalanine hydroxylase (PhhA) is encoded by the first structural gene (phhA), and carbinolamine dehydratase is encoded by the second structural gene (phhB) of the phh operon (Fig. 1A). Subclone analysis with Escherichia coli suggested that phhB was required for in vivo function of phhA. Thus, in the absence of the phhB gene, phhA by itself was unable to complement E. coli tyrosine auxotrophy. Since the mammalian counterpart of PhhB is a bifunctional protein endowed with both enzymatic activity and regulatory activity, the foregoing observation suggested that the bacterial PhhB might also have a regulatory function. This possibility has been further enhanced by recent reports of structural features shared by PhhB and DCoH. The three-dimensional structures for mammalian DCoH (6) and P. aeruginosa PhhB (7) have been resolved, revealing superimposable three-dimensional structures. Each contains a saddle-shaped groove which is believed to comprise a probable macromolecule-binding site. The structure also manifests a protein motif reminiscent of the molecular saddle seen in the TATA binding protein (19). However, DCoH affinity for DNA or RNA has not been observed (16, 23). The relationship of the conserved structural features to the regulation mechanism operating in organisms as diverse as humans and bacteria is a very intriguing question. In this context of broad significance, we examined the regulatory properties of PhhB in P. aeruginosa.

MATERIALS AND METHODS

Bacterial strains, plasmids, phages, and media.

The bacterial strains, plasmids, and phages used in this study are listed in Table 1. The Luria-Bertani (LB) and M9 formulations (24) were used as enriched and minimal growth media, respectively. Pseudomonas isolation agar (Difco) was used for isolating P. aeruginosa knockout mutants. Additions of ampicillin (100 μg/ml), chloramphenicol (40 μg/ml), kanamycin (50 μg/ml), mercury chloride (15 μg/ml), phenylalanine (50 μg/ml), and thiamine (17 μg/ml) were made as appropriate. Agar (Difco) was added at a final concentration of 2% (wt/vol) for preparation of solid medium.

TABLE 1.

Bacterial strains, plasmids, and phages used in this study

Strain, plasmid, or phage Genotype or description Source or reference
Strains
E. coli
  BL21(DE3) FompT hsdSB(rB mB) gal dcm; with DE3, a λ prophage carrying the T7 RNA polymerase gene Novagen
  DH5α F ΔlacU169 f80 dlacZΔM15 hsdR17 recA1 endA1 gyrA96 thi-1 relA1 supE44 GIBCO/BRL
  LE392 Fel4 mutant (McrA) hsdR514 (rK mK+) supE44 supF58 lacY1 or Δ(lacIZY)6 galK galT22 metB1 trpR55 24
  JP2255 aroF363 pheA361 pheO352 tyrA382 thi-1 strR712 lacY1 xyl-15 1
  S17-1 [RP4-2 (Tc::Mu) (Km::Tn7) Tra (IncP)] pro hsdR recA Tpr Smr 27
  JS1 SP1313F(phhA′-lacZ) This study
  SP1313 zah-735::Tn10Δ(argF-lac)U169 Δ(tyrR) 9
P. aeruginosa
  PA01 Prototroph 10
  JS101 PA01 phhA Hgr 28
  JS102 PA01 phhR Hgr 28
  JS103 PA01 phhB Hgr This study
  JS104 PA01 phhC Hgr 8
Plasmids
 pUC18 Amprlac′IPOZ′ 32
 pUC19 Amprlac′IPOZ′ 32
 pACYC177 P15A replicon, Apr Kmr 2
 pET11b T7 lac promoter lacI+ Apr Novagen
 pET23 T7 lac promoter, lacI+ Apr Novagen
 pGEM-3Z T7 promoter, Apr Pomega
 pGST-DCoH In-frame protein fusion of glutathione S-transferase and DCoH 3
 pJS10 phhAB, 2.5-kb HincII fragment cloned into pGEM-3Z behind the T7 promoter This study
 pJS11 phhAB′, 1.44-kb HincII-EcoRV fragment cloned into pACYC177 This study
 pJS12 phhAB, 2.5-kb HincII fragment cloned into HincII site of pACYC177 This study
 pJS51 HincII-BamHI fragment containing truncated phhA′ cloned into pACYC177 This study
 pJS51Z phhA′-lacZ transcriptional fusion in pACYC177 This study
 pJS63 phh′ABC, BamHI-HindIII fragment cloned into pGEM-3Z behind the T7 promoter This study
 pJS72 phhA, PCR-generated fragment containing the native RBS and PhhA-coding region cloned into pET23 behind the T7 lac promoter This study
 pJS95 PhhA overexpression vector; PhhA-coding region fused with T7 translational initiation signal at NdeI site of pET11b This study
 pJS96 PhhA overexpression vector; phhA fused with the T7 translational initiation signal cloned into pUC19 behind lac promoter to constitutively overexpress PhhA This study
 pJS97 PhhA overexpression vector; phhA fused to the T7 translational signal cloned into pTrc99A behind the trc promoter This study
 pJS101 Hgr cassette, Apr 28
 pJS105 HincII-BamHI PCR fragment containing phhA′ with a frameshift This study
 pJS105Z phhA′-′lacZ protein fusion cloned into pACYC177 This study
 pJZ9 phhRABC Apr 34
 pJZ9-3a phhAB Apr 34
 pJZ9-4 phh′ABC Apr 34
 pJZ9-5 phhAB′ Apr 34
 pMC1871 lacZ protein fusion vector Pharmacia
 pTrc99A trc promoter, lacI+ Apr Pharmacia
 pUFR004 ColE1 replicon, Cmr Mob+mobP lacZa+ 5
 Z1918 Promoterless lacZ, Apr 26
Phages
 λRZ5 λ ′bla ′lacZ lacY+ 21
 λJS1 λφ(phhA′-lacZ) lacY+ ′bla This study

Recombinant DNA techniques.

Molecular cloning and DNA manipulation, including plasmid purification, restriction enzyme digestion, ligation, and transformation, were conducted by standard methods (24). DNA fragments were purified from agarose gel with a GeneClean kit (Bio 101). Electroporation (Invitrogen) was used for simultaneous transformation of E. coli with two compatible plasmids. Restriction enzymes, T4 DNA ligase, DNA-modifying enzymes (New England Biolabs or Promega), Taq DNA polymerase (Perkin-Elmer), and Vent DNA polymerase (New England Biolabs) were used as recommended by the suppliers.

Phenylalanine hydroxylase assay.

E. coli JP2255 harboring pJZ9-3a was grown at 37°C in 500 ml of LB broth supplemented with ampicillin and harvested at the late-exponential phase of growth. Cell pellets were resuspended in 8 ml of 10 mM potassium phosphate buffer (pH 7.4) containing 1 mM dithiothreitol and were disrupted by sonication. The resulting extract was centrifuged at 150,000 × g for 1 h at 4°C. The supernatant was desalted with Sephadex G-25 and used as crude extract for the enzyme assay. PhhA activity was assayed by monitoring tyrosine formation (18).

Assay for PhhB activity.

PhhB activity in E. coli (pJZ9-4a) was assayed either indirectly by the phenylalanine hydroxylase stimulation assay (11, 15) or directly with a more straightforward assay (22).

Construction of phhA-lacZ transcriptional fusions.

For the transcriptional fusion (phhA′-lacZ), the HincII-BamHI fragment containing the upstream region of phhA was first cloned into pACYC177 (which had been digested with HincII and BamHI) to create pJS51. A BamHI cassette of a promoterless lacZ gene from Z1918 was then inserted at the BamHI site of pJS51 in the same orientation as the phhA gene to create pJS51Z, which was used as a multicopy phhA′-lacZ fusion. A single-copy phhA′-lacZ fusion was obtained by converting pJZ51Z into λ(phhA′-lacZ) by following the procedure described by Yu and Reznikoff (33).

Construction of phhA-lacZ translational fusions.

For the translational fusion (phhA′-′lacZ), the HincII-BamHI fragment containing the upstream region of the phhA gene was generated by PCR with the upstream primer 5′-GACAGAGCAGGTAGATGGCGTT-3′ and the downstream primer 5′-GGGATCCGGCTCGTGGGGCAGGCCGA-3′ (BamHI site underlined). An extra guanine nucleotide (in boldface type) was added in the downstream primer to create the frameshift needed for an in-frame fusion at the BamHI site to generate phhA′-′lacZ. The HincII-BamHI fragment with the frameshift was inserted into the HincII-BamHI site of pACYC177 to create pJS105, and a BamHI cassette of truncated ′lacZ from pMC1871 was inserted into pJS105 to create the translational fusion plasmid pJS105Z.

β-Galactosidase assay.

β-Galactosidase activity was assayed under conditions of proportionality as described by Miller (17), and specific activities are expressed in Miller units. The data are the results of at least two independent assays.

Construction of PhhA and PhhB overexpression vectors.

To express PhhA protein at high levels, the overexpression plasmids pJS72 and pJS95 were constructed. A PCR fragment containing the complete coding region of phhA and the native ribosome-binding site (RBS) was amplified by use of the upstream primer 5′-CATGGAGTCCGTATGAAAACGACGCA-3′ (RBS underlined; ATG start codon in boldface type) and the downstream primer 5′-CTTGGTTGTCGCATGTGGGAGCGGCG-3′ and cloned into pET23 behind the T7 lac promoter to create pJS72. pJS95 was constructed by inserting the coding region of phhA into the translational fusion vector pET11b. The coding region was amplified by PCR with the upstream primer 5′-CCATATGAAAACGACGCAGTACGTG-3′ and the downstream primer 5′-CAAGTCTGGTTGTCGCATGTGGGAGCGGCG-3′. The upstream primer was made with a built-in NdeI site (underlined), allowing fusion of phhA at the translational start site (ATG in boldface type) with the T7 translational initiation signals. To overexpress the PhhA protein constitutively, the phhA-coding region together with the upstream T7 translational start signals was excised from pJS95 as an XbaI fragment and cloned into pUC18 downstream of a lac promoter to create pJS96. The XbaI fragment was also cloned into pTrc99A downstream of the inducible trc promoter to create pJS97.

Two similar plasmids, pJS10 and pJS63, were constructed to overexpress PhhB. The HincII fragment containing both the phhA and the phhB gene was inserted into pGEM-3Z to create pJS10, and the BamHI-HindIII fragment containing both phhB and phhC was inserted into pGEM-3Z to create pJS63. In both plasmids, the phhB gene was under the control of a T7 promoter.

SDS-PAGE and Western blot analysis.

Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) (12% polyacrylamide) was performed with a Mini-PROTEAN II cell (Bio-Rad) by the method of Laemmli (14). Samples of exponential-phase cells were collected by centrifugation, and the cell pellets were suspended in gel loading buffer and heated at 100°C for 10 min. Samples of 5 to 10 μl were loaded onto two SDS-polyacrylamide gels. After separation of the proteins by electrophoresis, one gel was stained with Coomassie blue and the other gel was used for blotting. When crude extracts were used, equivalent amounts of protein were loaded into each lane. Western blots were performed according to the method of Towbin et al. (30). The proteins were electrophoretically transferred onto nitrocellulose membranes and reacted with the polyclonal antibodies raised against PhhA or PhhB in a rabbit. Quantitative estimates were made by densitometry.

Gene inactivation.

The PhhB gene was inactivated by following the method described by Song and Jensen (28). To generate the truncated ′phhB′ fragment (308 bp), the upstream primer 5′-ACCCAAGCCCATTGCGAAGCCTGCCG-3′ and the downstream primer 5′-GTGCGCGCCGCCATGATGAAATCGTT-3′ were used. Interruption of the phhB gene in an Hgr isolate was confirmed by Southern hybridization.

Immunoaffinity chromatography and immunoprecipitation assays for protein complex.

For immunoaffinity chromatography, anti-PhhB antibody was cross-linked to CNBr-activated Sepharose 4B which was packed into a 10-ml column and used according to the protocol described by the supplier (Pharmacia). The anti-PhhB affinity column was preequilibrated with buffer A (0.1 M potassium phosphate buffer [pH 7.4], 0.25 M NaCl, 1 mM dithiothreitol, 10 mM Fe2+). Crude extract of E. coli JP2255 harboring pJZ9-3a was applied to the anti-PhhB affinity column. After being washed extensively with buffer A (over 20 bed volumes), the column was eluted with 0.1 M glycine-HCl buffer (pH 2.8) and the collected fractions were analyzed for coelution of PhhA and PhhB by Western blotting.

Coimmunoprecipitation of PhhA and PhhB.

A crude extract prepared from E. coli JP2255 harboring pJZ9-3a was used as the enzyme source. The extract was mixed with anti-PhhA, anti-PhhB, or preimmune (control) serum in a ratio of 1:1 (vol/vol) and incubated at 25°C for 10 min just before the assays. The assays for phenylalanine hydroxylase activity in the antiserum-treated preparations were carried out as described above.

Biochemicals and molecular biology reagents.

Dihydropteridine reductase and 6,7-dimethyl-5,6,7,8-tetrahydropteridine were obtained from Sigma (St. Louis, Mo.). Rat liver phenylalanine hydroxylase was prepared by following a published protocol (13). Antisera to PhhA and PhhB were produced in rabbits (Cocalico Biologicals, Inc., Reamstown, Pa.). Restriction enzymes, T4 DNA ligase, DNA-modifying enzymes (New England Biolabs or Promega), and Taq DNA polymerase (Perkin-Elmer) were used as recommended by the suppliers. Other biochemical agents were purchased from Sigma or Aldrich. Inorganic chemicals (analytical grade) were from Fisher Scientific.

RESULTS

Trans-complementation of tyrosine auxotrophy by phhA and phhB.

Both phhA and phhB had been shown to be needed for functional complementation of tyrosine auxotrophs in E. coli (34), but it was unknown whether the requirement for phhB was cis or trans with respect to phhA. A trans-complementation study was done, and this ruled out a cis effect of phhB on the expression of phhA. phhA and phhB (or DCoH) were cloned into two compatible plasmids, pJS11 and pJZ9-4 (or pGST-DCoH), respectively. The results showed that phhB was able to complement E. coli tyrosine auxotrophy in trans with respect to phhA. Furthermore, mammalian DCoH was able to replace PhhB in the bacterial system.

Effect of phhB knockout in P. aeruginosa.

The phhB gene in P. aeruginosa was inactivated by interrupting the chromosomal phhB gene with insertion of the suicide plasmid pUFR/′phhB′/Hgr through a single homologous crossover event (28). The interruption of the phhB gene in the resulting mutant was confirmed by Southern blot analysis (data not shown).

To determine the effect of phhB knockout, we used Western blots to monitor the expression of PhhA and PhhB in the phhB mutant, along with other gene knockout strains (Fig. 2A). The PhhA level in the phhB mutant, compared to that of the wild-type strain, was reduced by about 2.5-fold. It was unchanged in a phhC knockout strain. PhhA was not detected in the phhA knockout mutant (negative control). The PhhA level was significantly reduced in the phhR knockout strain, as we previously reported (28). The absence of PhhB in the PhhA knockout strain is presumably due to the polar effect of the insertion.

FIG. 2.

FIG. 2

Activation of phhA expression by PhhB. (A) Western blot analysis of PhhA (top blot) and PhhB (bottom blot) levels in P. aeruginosa knockout mutants. Lanes from left to right were loaded with lysate preparations from the wild-type strain PA01 (WT) and its knockout mutant derivatives with gene interruptions in phhA, phhB, phhC, or phhR. Proteins in whole-cell lysates were separated by SDS-PAGE and probed with rabbit anti-PhhA or anti-PhhB polyclonal antibodies. (B) Western blot analysis of PhhA expression in E. coli JP2255. Proteins in the whole-cell lysates of JP2255 carrying the plasmids indicated below were separated by SDS-PAGE and reacted with rabbit anti-PhhA polyclonal antibodies. Plasmids containing the gene(s) indicated at the top of the gel were as follows: phhA, pJS11; phhB, pJZ9-4; and DCoH, pGST-DCoH. PUC18 was used as the control plasmid. The lower band in lane 2 is probably a fusion protein from pJZ9-4 which contains a fragment of phhA fused to the lacZ alpha fragment, which is recognized by the polyclonal anti-PhhA antibodies.

The physiological effect of the phhB knockout in P. aeruginosa was also examined. Inactivation of phhB abolished its ability to grow on either phenylalanine or tyrosine as the sole carbon source. However, since phhC has been found to be essential for growth on either phenylalanine or tyrosine as the sole carbon source (8), we do not know the extent to which this can be attributed to a polar effect of the insertion on downstream phhC.

PhhB regulates expression at the posttranscriptional level.

To determine whether the regulation of phhA expression by PhhB is exerted at the transcriptional or translational level, we constructed both transcriptional and translational fusions using lacZ as a reporter gene. For the transcriptional fusion, we constructed phhA′-lacZ fusions in both a multicopy form (pJS51Z) and a single-copy from [λ(phhA′-lacZ)]. In both cases, addition of PhhB (pJZ9-4) or DCoH (pGST-DCoH) did not result in a level of β-galactosidase higher than that in the control (pUC18) (Table 2), indicating that neither PhhB nor DCoH produced any effects at the transcriptional level.

TABLE 2.

Effect of phhB or DCoH supplied in trans upon expression of phhA in transcriptional or translational fusionsa

Plasmid used in trans Gene supplied in trans β-Galactosidase activityb
pJS51Z λJS1 pJS105Z
pJZ9-4 phhB 180.7 ± 40.6 13.2 ± 1.2 13.1 ± 0.1c
pGST-DCoH DCoH 190.6 ± 13.1 14.1 ± 0.8 10.4 ± 0.3c
pUC18 None 182.3 ± 16.3 15.7 ± 1.2 7.3 ± 0.7
a

Regulation of phhA expression was studied with lacZ as the reporter gene. β-Galactosidase activities in the transcriptional fusions pJS51Z (phhA′-lacZ) (multicopy) and λJS1 (phhA′-lacZ) (single copy) and the translational fusion pJS105Z (phhA′-′lacZ) (multicopy) were assayed in the absence and presence of either PhhB or DCoH. 

b

β-Galactosidase activities are reported in Miller units. Values are means (± standard deviations) of results from three independent experiments. 

c

Significantly higher than the value for the control (pUC18) (P < 0.0001 by analysis of variance). 

We also used a translational fusion phhA′-′lacZ (pJS105Z) (Table 2), and PhhB or DCoH was again provided in trans on a second plasmid. The results showed about a twofold increase in β-galactosidase activity, indicating that PhhB regulates the expression of phhA at a posttranscriptional level. Activation by PhhB measured in this way is consistent with the results obtained from Western blot analysis for both P. aeruginosa (Fig. 2A) and E. coli (Fig. 2B), where similarly modest levels of activation in phhA expression were observed.

PhhA protein is expressed in the absence of PhhB.

We expected the phhB knockout result with P. aeruginosa and the gene fusion experiments with E. coli (Table 2) to show much greater effects of PhhB’s absence than the relatively modest reductions in levels of PhhA that were observed. This was because in previous work (34), little or no PhhA had been detected in the absence of phhB (pJZ9-5) in E. coli whereas a very high level of PhhA was produced in the presence of phhB (pJZ9-3a). Therefore, we reevaluated the ability of PhhB to enhance the expression of phhA in E. coli JP2255 (Fig. 2B). A substantial level of PhhA was, in fact, detected when only phhA was present. A further twofold increase in PhhA level was found when either phhB or DCoH was also present. The latter results are consistent with the foregoing results with the P. aeruginosa phhB knockout mutant (Fig. 2A) and with the translational fusion results with E. coli (Table 2). The inconsistency between the result obtained with pJS11 (Fig. 2B, lane 2) and the result reported for pJZ9-5 (34) was found to be due to the incorrect orientation of the insert in pJZ9-5. Partial sequencing of pJZ9-5 revealed that the phhA gene was positioned opposite to the lac promoter, rather than in the same orientation as had been claimed.

Expression of PhhA without PhhB has growth-inhibitory effects in E. coli.

Since it is now clear that PhhA can be expressed in the absence of PhhB, the question arises as to why phhB is needed in combination with phhA for functional complementation. The most obvious consideration is whether blockage of pterin recycling stops the phenylalanine hydroxylase reaction in vivo. Although dihydropteridine reductase, one of two essential enzymes in recycling of the pterin cofactor, has been found in E. coli (31), 4a-carbinolamine dehydratase activity has not been detected in this bacterium and there is no ortholog of phhB present in the genome. Nevertheless, the absolute requirement for 4a-carbinolamine dehydratase activity to obtain complementation is perhaps surprising because this reaction proceeds to some extent nonenzymatically. It is possible that excessive utilization of an E. coli pterin in the absence of PhhB causes some nutritional limitation. We considered the possibility that tetrahydrofolate biosynthesis is affected and hence reduces the pool of methyl group donors. However, supplementation of DH5α/pJS96 on LB broth plates with l-methionine or with S-adenosylmethionine failed to relieve inhibition.

Another possibility for the requirement of 4a-carbinolamine dehydratase in complementation is its use to overcome some mechanism of toxicity, perhaps caused by an accumulated carbinolamine derivative such as 7-biopterin. Growth inhibition by PhhA was indeed demonstrated by comparison of two constructs having different basal levels of PhhA expression (Fig. 3A). In one construct the XbaI fragment from pJS95 carrying phhA (fused with φ10 translational signals) was cloned into pTrc99A behind the inducible trc promoter to create pJS97. pJS97 carries lacIq, and E. coli DH5α carrying pJS97 was plated on LB broth-ampicillin plates with different concentrations of IPTG (isopropyl-β-d-thiogalactopyranoside; 1 to 5 mM). A control plate with no IPTG added was also used. Pinpoint colonies emerged on the control plate after overnight incubation at 37°C, while 2 days was required to see pinpoint colonies on IPTG-containing plates. Progressively higher concentrations of IPTG correlated with greater elapsed times before visible colonies appeared. Thus, it appears that even the low basal output of PhhA from the strong trc promoter is sufficient to trigger growth inhibition. When E. coli DH5α carrying pJS96 (a plasmid construct where phhA is constitutively overexpressed from the lac promoter) was used, an elapsed time of several days was required to see pinpoint colonies. Both constructs, especially pJS96, are unstable and are readily lost from host cells. Given its relative lack of promoter leakiness, we were able to overexpress PhhA from pJS97 (Fig. 3B) upon IPTG induction. Because PhhA is constitutively overexpressed and because of the consequent selective pressure for a high rate of plasmid loss, we were not able to produce a high level of PhhA from pJS96 (Fig. 3B). Neither pJS96 nor pJS97 alone was able to complement E. coli tyrosine auxotrophy; however, they were able to complement the auxotrophy with the additional provision of phhB in trans on pJZ9-4 (data not shown).

FIG. 3.

FIG. 3

Expression of PhhA in E. coli JP2255. (A) Construction of the PhhA expression plasmids pJS96 and pJS97. (B) SDS-PAGE analysis of PhhA expression. Proteins in whole-cell lysates were separated by SDS-PAGE and stained with Coomassie blue. Lane 1, JP2255/pJS96; lane 2, JP22255/pTrc99A (control); lanes 3 and 4, JP2255/pJS97 before and after induction with 1 mM IPTG for 3 h at 30°C, respectively; lane 5, molecular weight markers (in thousands).

Coexpression of PhhA and PhhB in P. aeruginosa.

Expression of both phhA and phhB was induced by the presence of phenylalanine in P. aeruginosa grown on a minimal fructose-based medium (Fig. 4). Coinduction of phhA and phhB were expected, since they coexist in the phh operon. However, a basal level of PhhB was expressed under noninducing conditions as seen in Fig. 4, lane 2, on the Western blot, whereas PhhA was not detected. This result suggests the existence of default expression of phhB from a weak, internal promoter under noninducing conditions.

FIG. 4.

FIG. 4

Induction of the phh operon by phenylalanine in P. aeruginosa. Proteins in the whole-cell lysates were separated by SDS-PAGE (12%). Lane 1, E. coli JP2255 harboring both pJS11 and pJZ9-4; lanes 2 to 7, samples taken from wild-type P. aeruginosa PA01 grown on M9 minimal medium after elapsed times of 0, 10, 30, 60, 90, and 120 min, respectively, following addition of 100 μg of l-phenylalanine per ml at zero time.

PhhA and PhhB form a complex.

We noticed that when crude extracts of E. coli(pJZ9-3a), which possesses both PhhA and PhhB, were treated with antibody to PhhB, effective immunoprecipitation of PhhA occurred (Table 3). Since the anti-PhhB antibody does not affect PhhA alone, we conclude that PhhA and PhhB can exist as a dissociable complex. Anti-PhhB antibody presumably precipitates PhhA indirectly by virtue of the protein-protein association of PhhA and PhhB. Consistent with this conclusion were the results of affinity chromatography in which anti-PhhB antibody was immobilized on an affinity column (see Materials and Methods). Passage of extract containing both PhhA and PhhB through the column resulted in retention of both PhhA and PhhB.

TABLE 3.

Immunoprecipitation of PhhA activity by anti-PhhB antibody in the presence of PhhBa

Antibodyb Sp actc Relative activityd
Preimmune serum 54.8 ± 1.9 100
Anti-PhhA serum 12.2 ± 0.6* 22.3
Anti-PhhB serum 14.9 ± 0.6* 27.3
a

E. coli (pJZ9-3a) crude extract containing both PhhA and PhhB was used as the enzyme source in the assay. 

b

Rabbit antisera against PhhA and PhhB and preimmune serum (control) were used. 

c

The specific activity of phenylalanine hydroxylase is defined as nanomoles of tyrosine formed per minute per milligram of protein and is expressed as a mean value ± the standard deviation. *, significantly different from the value for the preimmune control (P < 0.001). 

d

Relative activity is expressed as a percentage of the activity of the control (preimmune serum). 

DISCUSSION

Phenylalanine hydroxylase in nature.

Phenylalanine hydroxylase systems appear to be of infrequent occurrence in prokaryotes. Phenylalanine hydroxylase has been reported in a few species belonging to the α division of the class Proteobacteria and is so far restricted to P. aeruginosa in the γ division (reference 34 and references therein). Of these, P. aeruginosa is the best characterized at the molecular-genetic level (28, 34), and the phh operon of P. aeruginosa is thus far unique. At this time homologs of pterin carbinolamine dehydratase encoded by phhB have not been reported for any other prokaryote. With the completion of the P. aeruginosa genome pending, it will be interesting to examine the exact enzymes of pterin biosynthesis that are present. Elucidation of the exact pathway of tyrosine catabolism used in P. aeruginosa is also forthcoming.

Toxicity triggered by PhhA expression.

Mammalian defects in either of the enzymes required for pterin cofactor recycling, pterin carbinolamine dehydratase and dihydropteridine reductase, cause malignant hyperphenylalaninemia. E. coli tyrosine auxotrophs cannot be complemented by P. aeruginosa phhA in the absence of phhB (34). This result was interpreted to be the consequence of a positive regulatory effect of phhB upon phhA expression since no PhhA enzyme activity was measured (34). However, the construct used before was found to have an orientation opposite to that reported. The correct construct yields cell populations which do express PhhA in the absence of PhhB, albeit at reduced levels. What then accounts for the inability of plasmid constructs containing phhA alone to complement tyrosine auxotrophy in E. coli? One obvious possibility is that phhB is simply necessary in vivo in order to maintain pterin recycling, to ensure the availability of a reduced pterin to PhhA. However, one might have expected at least to obtain slow-growing tyrosine-independent transformants due to nonenzymatic dehydration. A second possibility to account for the inability of PhhA to function in vivo in the absence of PhhB is toxicity caused by PhhA. Indeed, we found strong growth inhibition in E. coli strains in which phhA was expressed in the absence of phhB under growth conditions where PhhA conferred no selective value. 7-Biopterin is nonenzymatically produced from the pterin product formed (4a-hydroxytetrahydro-biopterin) after utilization of BH4 during PhhA catalysis in the absence of carbinolamine dehydratase, and 7-biopterin may be toxic. Perhaps it interferes with some pterin-dependent system of E. coli.

It is quite possible that E. coli (and P. aeruginosa) provides PhhA with a functional pterin cofactor other than BH4. The complete E. coli genome contains genes for GTP cyclohydrolase I (EC 3.5.4.16) and 6-pyruvoyltetrahydropterin synthase (EC 4.6.1.10). Sepiapterin reductase, which can accomplish the two-step conversion of 6-pyruvoyltetrahydropterin to BH4, appears to be absent. Perhaps another reductase which is the functional equivalent of sepiapterin reductase is present. The most parsimonious explanation is that 6-pyruvoyltetrahydropterin is the pterin moiety utilized in vivo, but its lability seemingly rules this out. Another possibility is utilization of tetrahydroneopterin by PhhA and the ability of dihydropteridine reductase to recognize dihydroneopterin (which is present in E. coli). If so, growth inhibition in the presence of P. aeruginosa phhA may be due to the carbinolamine derivative generated from tetrahydroneopterin during phhA catalysis, an effect rescued by the carbinolamine dehydratase activity of PhhB.

Regulatory relationships between phhA and phhB.

The phh operon contains the three structural genes phhA, phhB, and phhC and the divergently transcribed, positively acting regulatory gene phhR, as illustrated in Fig. 1. phhA and phhB have been shown to be subject to coordinate induction when either phenylalanine or tyrosine is present in the growth medium. Levels of PhhC could not be monitored due to lack of specific antibody and the presence of other aminotransferase species with overlapping substrate specificities. Since phhC and phhB are translationally coupled, it is likely that phhC and phhB are expressed coordinately. Under growth conditions where induction is not promoted by addition of aromatic amino acids, the expression of phhA and that of phhB are not coordinate. PhhA cannot be detected, whereas PhhB maintains a distinct basal level of activity, which suggests that a weak internal promoter may lie between phhA and phhB to ensure basal levels of PhhB (and PhhC).

PhhB exerts a positive regulatory effect upon levels of expression of PhhA, an effect which was consistently two- to threefold in magnitude. Since the quantitative effect of the presence of PhhB in E. coli was the same as in P. aeruginosa, the positive regulatory effect of phhB must be independent of phhR (because E. coli lacks phhR). We found that PhhB regulates phhA at the posttranscriptional level. This result is contrary to results reported elsewhere, but no data were given (16). Among the possible mechanisms of activation are that (i) PhhB may bind to phhA mRNA and either enhance translational initiation or protect the mRNA from degradation and (ii) PhhB may directly bind to PhhA and promote some catalytic or stability enhancement. Consistent with the latter possibility are results which indicate that PhhA and PhhB form a dissociable protein-protein complex.

ACKNOWLEDGMENTS

We thank S. Kaufman for providing purified rat liver phenylalanine hydroxylase and J. Ayling for suggesting the possible alternative pterin recycling mechanisms which might be employed by E. coli.

Footnotes

Florida Agricultural Experiment Station Journal series no. R-06836.

REFERENCES

  • 1.Baldwin G S, Davidson B E. A kinetic and structural comparison of chorismate mutase/prephenate dehydratase from mutant strains of Escherichia coli K-12 defective in the pheA gene. Arch Biochem Biophys. 1981;211:66–75. doi: 10.1016/0003-9861(81)90430-6. [DOI] [PubMed] [Google Scholar]
  • 2.Chang A C Y, Cohen S N. Construction and characterization of amplifiable multicopy DNA cloning vehicles derived from the p15A cryptic miniplasmid. J Bacteriol. 1978;134:1141–1156. doi: 10.1128/jb.134.3.1141-1156.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Citron B A, Davis M D, Milstien S, Gutierrez J, Mendel D B, Crabtree G R, Kaufman S. Identity of 4a-carbinolamine dehydratase, a component of the phenylalanine hydroxylation system, and DCoH, a transregulator of homeodomain proteins. Proc Natl Acad Sci USA. 1992;89:11891–11894. doi: 10.1073/pnas.89.24.11891. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Curtius H C, Adler C, Rebrin I, Heizmann C, Ghisla S. 7-Substituted pterins: formation during phenylalanine hydroxylation in the absence of dehydratase. Biochem Biophys Res Commun. 1990;172:1060–1066. doi: 10.1016/0006-291x(90)91554-6. [DOI] [PubMed] [Google Scholar]
  • 5.DeFeyter R, Kado C I, Gabriel D W. Small, stable shuttle vectors for use in Xanthomonas. Gene. 1990;88:65–72. doi: 10.1016/0378-1119(90)90060-5. [DOI] [PubMed] [Google Scholar]
  • 6.Endrizzi J A, Cronk J F, Wang W, Crabtree G R, Alber T. Crystal structure of DCoH, a bifunctional, protein-binding transcriptional coactivator. Science. 1995;268:556–559. doi: 10.1126/science.7725101. [DOI] [PubMed] [Google Scholar]
  • 7.Ficner R, Sauer U H, Stier G, Suck D. Three-dimensional structure of the bifunctional protein PCD/DCoH, a cytoplasmic enzyme interacting with transcriptional factor HNF1. EMBO J. 1995;14:2034–2042. doi: 10.1002/j.1460-2075.1995.tb07195.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Gu W, Song J, Bonner C A, Xie G, Jensen R A. PhhC, an essential aminotransferase for aromatic amino acid catabolism in Pseudomonas aeruginosa. Microbiology. 1998;144:3127–3134. doi: 10.1099/00221287-144-11-3127. [DOI] [PubMed] [Google Scholar]
  • 9.Heatwole V M, Somerville R L. The tryptophan-specific permease gene, mtr, is differentially regulated by the tryptophan and tyrosine repressors in Escherichia coli K-12. J Bacteriol. 1991;173:3601–3604. doi: 10.1128/jb.173.11.3601-3604.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Holloway B W. Genetic recombination in Pseudomonas aeruginosa. J Gen Microbiol. 1955;13:572–581. doi: 10.1099/00221287-13-3-572. [DOI] [PubMed] [Google Scholar]
  • 11.Huang C Y, Max E E, Kaufman S. Purification and characterization of phenylalanine hydroxylase-stimulating protein from rat liver. J Biol Chem. 1973;248:4235–4241. [PubMed] [Google Scholar]
  • 12.Kaufman S, Citron B A, Davis M, Milstien S. The isolation and characterization of clones of 4a-hydroxytetrahydrobiopterin dehydratase. Adv Exp Med Biol. 1993;338:97–102. doi: 10.1007/978-1-4615-2960-6_19. [DOI] [PubMed] [Google Scholar]
  • 13.Kaufman S, Fisher D B. Purification and some physical properties of phenylalanine hydroxylase from rat liver. J Biol Chem. 1970;245:4745–4750. [PubMed] [Google Scholar]
  • 14.Laemmli U K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  • 15.Lazarus R A, Benkovic S J, Kaufman S. Phenylalanine hydroxylase stimulation protein is a 4a-carbinolamine dehydratase. J Biol Chem. 1983;258:10960–10962. [Google Scholar]
  • 16.Mendel D B, Crabtree G R. HNF1, a member of a novel class of dimerizing homeodomain proteins. J Biol Chem. 1991;266:677–680. [PubMed] [Google Scholar]
  • 17.Miller J H. Experiments in molecular genetics. Cold Spring Harbor, N.Y: Cold Spring Harbor Laboratory Press; 1972. [Google Scholar]
  • 18.Nakata H, Yamauchi T, Fujisawa H. Phenylalanine hydroxylase from Chromobacterium violaceum: purification and characterization. J Biol Chem. 1979;266:18454–18459. [PubMed] [Google Scholar]
  • 19.Nikolov D B, Hu S H, Lin J, Gasch A, Hoffmann A, Horikoshi M, Chua N H, Roeder R G, Burley S K. Crystal structure of TFIID TATA-box binding protein. Nature. 1992;360:40–46. doi: 10.1038/360040a0. [DOI] [PubMed] [Google Scholar]
  • 20.Pogge von Strandmann E, Ryffel G U. Developmental expression of the maternal protein XDCoH, the dimerization cofactor of the homeoprotein LFB1 (HNF1) Development. 1995;121:1217–1226. doi: 10.1242/dev.121.4.1217. [DOI] [PubMed] [Google Scholar]
  • 21.Rosentel J K, Healy F, Maupin-Furlow J A, Lee J H, Shanmugam K T. Molybdate and regulation of mod (molybdate transport), fdhF, and hyc (formate hydrogenlyase) operons in Escherichia coli. J Bacteriol. 1995;177:4857–4864. doi: 10.1128/jb.177.17.4857-4864.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Rebrin I, Ayling J E, Song J, Jensen R A. Mechanistic studies of 4a-hydroxytetrahydropterin dehydratase from Pseudomonas aeruginosa. In: Pfleiderer W, Rokas H, editors. Chemistry and biology of pteridines and folates. Oxford, United Kingdom: Blackwell Scientific; 1997. pp. 631–634. [Google Scholar]
  • 23.Rhee K-H, Stier G, Becker P B, Suck D, Sandaltzopoulos R. The bifunctional protein DcoH modulates interactions of the homoeodomain transcription factor HNF1 with nucleic acids. J Mol Biol. 1997;265:20–29. doi: 10.1006/jmbi.1996.0708. [DOI] [PubMed] [Google Scholar]
  • 24.Sambrook J, Fritsch E F, Maniatis T. Molecular cloning: a laboratory manual. 2nd ed. Cold Spring Harbor, N.Y: Cold Spring Harbor Press; 1989. [Google Scholar]
  • 25.Schallreuter K U, Wood J M, Pittelkow M R, Gutlich M, Lemke K R, Rodl W, Swanson N N, Hitzemann K, Ziegler I. Regulation of melanin biosynthesis in the human epidermis by tetahydrobiopterin. Science. 1994;263:1444–1446. doi: 10.1126/science.8128228. [DOI] [PubMed] [Google Scholar]
  • 26.Schweizer H P. Two plasmids, X1918 and Z1918, for easy recovery of the xylE and lacZ reporter genes. Gene. 1993;134:89–91. doi: 10.1016/0378-1119(93)90178-6. [DOI] [PubMed] [Google Scholar]
  • 27.Simons R W, Houman F, Kleckner N. Improved single and multicopy lac-based cloning vectors for protein and operon fusions. Gene. 1983;53:85–96. doi: 10.1016/0378-1119(87)90095-3. [DOI] [PubMed] [Google Scholar]
  • 28.Song J, Jensen R A. PhhR, a divergently transcribed activator of the phenylalanine hydroxylase gene cluster of Pseudomonas aeruginosa. Mol Microbiol. 1996;22:497–507. doi: 10.1046/j.1365-2958.1996.00131.x. [DOI] [PubMed] [Google Scholar]
  • 29.Thöny B, Neuheiser F, Kierat L, Blaskovics M, Arn P H, Ferreira P, Rebrin I, Ayling J, Blau N. Hyperphenylalaninemia with high levels of 7-biopterin is associated with mutations in the PCBD gene encoding the bifunctional protein pterin-4a-carbinolamine dehydratase and transcriptional coactivator (DcoH) Am J Hum Genet. 1998;62:1302–1311. doi: 10.1086/301887. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA. 1979;76:4350–4354. doi: 10.1073/pnas.76.9.4350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Vasudevan S G, Shaw D C, Armarego W L F. Dihydropteridine reductase from Escherichia coli. Biochem J. 1988;255:581–588. [PMC free article] [PubMed] [Google Scholar]
  • 32.Yanisch-Perron C, Vieira J, Messing J. Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC vectors. Gene. 1985;33:103–119. doi: 10.1016/0378-1119(85)90120-9. [DOI] [PubMed] [Google Scholar]
  • 33.Yu X-M, Reznikoff W S. Deletion analysis of the CAP-cAMP binding site of the Escherichia coli lactose promoter. Nucleic Acids Res. 1984;12:5449–5464. doi: 10.1093/nar/12.13.5449. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Zhao G, Xia T, Song J, Jensen R A. Pseudomonas aeruginosa possesses homologues of mammalian phenylalanine hydroxylase and 4a-carbinolamine dehydratase/DCoH as part of a three-component gene cluster. Proc Natl Acad Sci USA. 1994;91:1366–1370. doi: 10.1073/pnas.91.4.1366. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Bacteriology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES